A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. Wingerchuk DM, Lesaux J, Rice GPA, Kremenchutzky M, Ebers GC J Neurol Neurosurg Psychiatry. 2005 Sep; 76(9):1294-6. PMID: 16107372. Abstract CommentRecommendBookmarkWatch